This is the authors' abstract. We don't add key points for this paper.
Background: Scalp platelet-rich plasma (PRP) injections are used in treating androgenetic alopecia (AGA). Pain during scalp PRP injections is a major limiting factor, yet no standardized pain control protocol exists. The study aimed to evaluate the impact topical anesthetics had on the pain experienced during scalp PRP injections and to identify associated factors. Methodology: This was a cross-sectional descriptive study, conducted at a tertiary care center from March to July 2024. Patients with AGA undergoing scalp PRP injections were enrolled after obtaining informed consent. The Dermatology Life Quality Index was administered to assess the quality of life, and the Amsterdam Perioperative Anxiety and Information Scale (APAIS) was used to evaluate preprocedure anxiety. Topical eutectic mixture of local anesthetics (EMLA) was applied under occlusion for 1 h. Scalp PRP injections were administered, and pain was rated with the Numerical Pain Rating Scale (NPRS) immediately at the end of the procedure (EOP-NPRS) and after 24 h postprocedure (PP-NPRS) and correlated with associated factors. Results: Forty subjects (30 males, 10 females) were included in the study. The mean EOP-NPRS and PP-NPRS were 6.28 (standard deviation [SD] = 2.12), indicative of moderate pain, and 3.76 (SD = 2.01), respectively. EOP-NPRS scores had a moderate correlation with total APAIS scores ( r = 0.371, P = 0.018). A moderate inverse correlation was observed between age and EOP-NPRS ( r = −0.379, P = 0.016). Conclusion: EMLA is inadequate for pain control during scalp PRP injections. Pain persists postprocedure, underscoring the need for postprocedure analgesics. Anxious and younger patients experience more pain.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kartha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: